Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Leap Therapeutics Inc banner

Leap Therapeutics Inc
NASDAQ:CYPH

Watchlist Manager
Leap Therapeutics Inc Logo
Leap Therapeutics Inc
NASDAQ:CYPH
Watchlist
Price: 0.648 USD -1.52% Market Closed
Market Cap: $69m
Write Note Create Alert Ask AI

Wall St Price Targets

CYPH Price Targets Summary
Leap Therapeutics Inc

Wall Street analysts forecast CYPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CYPH is 0.918 USD with a low forecast of 0.909 USD and a high forecast of 0.945 USD.

CYPH Lowest Forecast
Wall Street Target
$0.909
40% Upside
CYPH Average Forecast
Wall Street Target
$0.918
42% Upside
CYPH Highest Forecast
Wall Street Target
$0.945
46% Upside
Lowest Forecast
Price Target
0.909 USD
40% Upside
Average Forecast
Price Target
0.918 USD
42% Upside
Highest Forecast
Price Target
0.945 USD
46% Upside
Leap Therapeutics Inc Competitors:
Price Targets
PRQR
ProQR Therapeutics NV
396% Upside
QNST
Quinstreet Inc
-6% Downside
PRQR
ProQR Therapeutics NV
396% Upside
QNST
Quinstreet Inc
-6% Downside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Leap Therapeutics Inc

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Leap Therapeutics Inc

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss

What are analyst estimates?

Continue CYPH Research

Summary
CYPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
CYPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CYPH stock valuation using valuation multiples.
Wall St Estimates
CYPH price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CYPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Leap Therapeutics Inc listings:
NASDAQ • USD
LPTX
 F • EUR
5MC1
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CYPH's stock price target?
Price Target
0.918 USD

According to Wall Street analysts, the average 1-year price target for CYPH is 0.918 USD with a low forecast of 0.909 USD and a high forecast of 0.945 USD.

Back to Top
ALPHA SPREAD
Follow us
Join 353,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett